Advisornet Financial’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,140
Closed -$30.8K 2287
2024
Q2
$30.8K Hold
1,140
﹤0.01% 971
2024
Q1
$20.9K Sell
1,140
-3,145
-73% -$49.9K ﹤0.01% 1060
2023
Q4
$52.6K Hold
4,285
﹤0.01% 798
2023
Q3
$64.2K Hold
4,285
0.01% 721
2023
Q2
$139K Buy
4,285
+2,685
+168% +$98K 0.01% 560
2023
Q1
$62.6K Hold
1,600
0.01% 738
2022
Q4
$84.6K Hold
1,600
0.01% 660
2022
Q3
$72K Hold
1,600
0.01% 745
2022
Q2
$58K Hold
1,600
0.01% 826
2022
Q1
$66K Hold
1,600
﹤0.01% 880
2021
Q4
$68K Hold
1,600
﹤0.01% 919
2021
Q3
$88K Hold
1,600
0.01% 835
2021
Q2
$77K Hold
1,600
0.01% 855
2021
Q1
$81K Buy
+1,600
New +$88.9K 0.01% 811

Other funds holding SILK

Advisornet Financial's SILK Position: Q3 2024 in Review

Advisornet Financial sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 1,140 shares — an estimated $30.8K sold.

Advisornet Financial first reported a position in SILK in Q1 2021 and held it in 14 quarters. The position peaked at $139K in Q2 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Advisornet Financial reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Advisornet Financial sold 1,140 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $30.8K.
  • Advisornet Financial first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2021 and held it in 14 quarters.
  • Advisornet Financial's Silk Road Medical, Inc. Common Stock position peaked at $139K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Advisornet Financial's 13F filing for Q3 2024, filed 15 Oct 2024.